Binding of Tyr-W-MIF-1 (Tyr-Pro-Trp-Gly-NH2) and related peptides to μ1 and μ2 opiate receptors

Neuroscience Letters

Volumn 215, Issue 1, 1996, Pages 65-69

  Zadina, J E ^a   Paul, D ^b   Gergen, K A ^a   Ge, L J ^a   Hackler, L ^a   Kastin, A J ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

Author keywords

Analgesia; Calf thalamus; Cyclized analog; Hemorphin; Morphiceptin; Tyr MIF 1; Tyr W MIF 1

Indexed keywords

BETA FUNALTREXAMINE; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; HEMORPHIN; MORPHICEPTIN; MU OPIATE RECEPTOR; NALOXONAZINE; NEUROPEPTIDE; OPIATE PEPTIDE; RECEPTOR SUBTYPE; TYROSYLPROLYLLEUCYLGLYCINAMIDE; TYROSYLPROLYLTRYPTOPHYLGLYCINAMIDE; UNCLASSIFIED DRUG;

ADOLESCENT; ANALGESIA; ANIMAL TISSUE; ARTICLE; BRAIN HOMOGENATE; CATTLE; CONTROLLED STUDY; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING;

EID: 0030606830     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(96)12928-1     Document Type: Article

References (27)

1. Brantl V., Gramsch C., Lottspeich F., Mertz R. Jaeger, K-H. and Herz, A., Novel opioid peptides derived from hemoglobin: hemorphins. Eur. J. Pharmacol. 125:1986;309-310.
2. 50) of an enzyme reaction. Biochem. Pharmacol. 22:1973;3099-3102.
3. 1 binding assay. J. Pharmacol. Exp. Ther. 34:1988;308-317.
4. 2 (Tyr-W-MIF-1). Peptides. 13:1992;623-631.
5. Erchegyi J., Zadina J.E., Qiu X.-D., Kersh D.C., Ge L.-J., Brown M., Kastin A.J. Structure-activity relationships of analogs of the endogenous brain peptides Tyr-MIF-1 and Tyr-W-MIF-1. Peptide Res. 6:1993;31-38.
6. Fukuda K., Kato S., Mori K. Location of regions of the opioid receptor involved in selective agonist binding. J. Biol. Chem. 270:1995;6702-6709.
7. 2). Peptides. 15:1994;1505-1511.
8. 2-adrenoceptors. Eur. J. Pharmacol. 298:1996;235-239.
9. Hackler L., Kastin A.J., Erchegyi J., Zadina J.E. Isolation of Tyr-W-MIF-1 from bovine hypothalami. Neuropeptides. 24:1993;159-164.
10. Heyman J.S., Williams C.L., Burks T., Mosberg H.I., Porreca F. Dissociation of opioid antinociception and central gastrointestinal propulsion in the mouse: studies with naloxonazine. J. Pharmacol. Exp. Ther. 245:1988;238-243.
11. Horvath A., Kastin A.J. Isolation of tyrosine-melanocyte-stimulating hormone release-inhibiting factor 1 from bovine brain tissue. J. Biol. Chem. 264:1989;2175-2179.
12. 2) in human brain cortex. Int. J. Peptide Protein Res. 36:1990;281-284.
13. Kastin A.J., Banks W.A., Hahn K., Zadina J.E. Extreme stability of Tyr-MIF-1 in CSF. Neurosci. Lett. 174:1994;26-28.
14. Maness L.M., Banks W.A., Zadina J.E., Kastin A.J. Periventricular penetration and disappearance of ICV Tyr-MIF-1 DAMGO, tyrosine, and albumin. Peptides. 17:1996;247-250.
15. Pasternak G.W., Wood P.J. Minireview: multiple mu opiate receptors. Life Sci. 38:1986;1889-1898.
16. Paul D., Bodnar R.J., Gistrak M.A., Pasternak G.W. Different μ receptor subtypes mediate spinal and supraspinal analgesia in mice. Eur. J. Pharmacol. 168:1989;307-3l4.
17. Paul D., Hornby P.J. Potentiation of intrathecal DAMGO antinociception, but not gastrointestinal transit inhibition, by 5-hydroxytryptamine and norepinephrine uptake blockade. Life Sci. 56:1994;PL83-PL87.
18. Pick C.G., Nejat R.J., Pasternak G.W. Independent expression of two pharmacologically distinct supraspinal mu analgesic systems in genetically different mouse strains. J. Pharmacol. Exp. Ther. 265:1993;166-171.
19. Pick C.G., Paul D., Pasternak G.W. Comparison of naloxonazine and β-funaltrexamine antagonism of μ1 and μ2 opioid actions. Life Sci. 48:1991;2005-2011.
20. Ward S.J., LoPresti D., James D.W. Activity of mu- and delta-selective opioid agonists in the guinea pig ileum preparation: differentiation into peptide and nonpeptide classes with β-funaltrexamine. J. Pharmacol. Exp. Ther. 238:1986;625-631.
21. Wigdor S., Wilcox G.L. Central and systemic morphine-induced antinociception in mice: contribution of descending serotonergic and noradrenergic pathways. J. Pharmacol. Exp. Ther. 242:1987;90-95.
22. Zadina J.E. Kastin, AJ., Ge, L.-J., Gulden, H. and Bungart, KJ., Chronic, but not acute, administration of morphine alters antiopiate (Tyr-MIF-1) binding sites in rat brain. Life Sci. 44:1989;555-561.
23. Zadina J.E., Kastin A.J., Ge L.-J., Hackler L. Mu, delta and kappa opiate receptor binding of Tyr-MIF-1 and Tyr-W-MIF-1, its active fragments, and two potent analogs. Life Sci. 55:1994;PL461-466.
24. 2) with prolonged analgesic activity and potency comparable to DAMGO. Peptides. 15:1994;1567-1569.
25. 2). Neurosci. Lett. 155:(Tyr-Pro-Trp-Gly-NH2):1993;220-222.
26. Zadina J.E. Kastin, A.J., Kersh, D. and Wyatt, A, Tyr-MIF-1 and hemorphin can act as opiate agonists as well as antagonists in the guinea pig ileum. Life Sci. 51:1992;869-885.
27. Gergen. K.A., Zadina, J.E. and Paul, D. Analgesic effects of Tyr-W-MIF-1: a mixed μ2-opioid receptor agonist/μ1-opioid receptor antagonist. Eur. J. Pharmacol., (1996) in press.